Learn more about our upcoming Galas and Signature Events Learn More
Superyacht Captain, TV Personality, Melanoma Patient and Advocate Poised to Emcee Event Honoring the Melanoma Community New York City, NY (September 11, 2025) – The...
#GivingTuesday is TOMORROW! Join Sheila in Supporting the MRF. #GivingTuesday is in less than 24 hours! Your tax-deductible gift received on #GivingTuesday will help...
#GivingTuesday is TOMORROW, December 1! Join Graham in Supporting the MRF. During the holiday season, we are especially grateful for the children in our lives and th...
#GivingTuesday is Tuesday, December 1, 2015! Join Julie and Amelia in Supporting the MRF. #GivingTuesday is Tuesday, December 1 and your gift to the Melanoma Researc...
Ocular melanoma survivor Anne Marie Montijo reflects on the passing of Dr. Oliver Sacks and her own goal to live each day with a spirit of gratitude.
Today, the FDA approved the targeted therapy combination of vemurafenib (Zelboraf®) with cobimetinib (Cotellic) for people who have advanced or metastatic melanoma and who...
Washington, D.C. – On Saturday, November 7th, the Washington, D.C. melanoma community will come together to honor those who have been impacted by melanoma and raise f...
The results are in and #CUREOM Unite! was a tremendous success! Thank you to everyone who gave so generously to this campaign to further patient-centered ocular melanoma (O...
Statement from Tim Turnham, Executive Director, Melanoma Research Foundation Washington, D.C.—Today the Food and Drug Administration (FDA) approved ipilimumab ...
Today the FDA approved Amgen’s drug, Imlygic (Talimogene Laherparepvec or T-VEC), for the treatment of unresectable Stage IIIB, IIIC or IV metastatic melanoma, bringing a...
For the last decade, Dr. Richard Carvajal has dedicated his career to the research and treatment of rare cancers like ocular melanoma (OM) and understands the need for more...
Guest blogger Connie Popp shares her experience as an ocular melanoma caregiver, advocate and participant in Miles for Melanoma in support of the CURE OM Unite! campaign. 3 Minute Read
Statement from Tim Turnham, Executive Director, Melanoma Research Foundation The Melanoma Research Foundation (MRF) applauds the FDA’s approval of the c...
Oct 30, 2025 ET
